Aldo Bonaventura

Phase 1B, Randomized, Double-Blinded, Dose Escalation, Single-Center, Repeat Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor Dapansutrile in Subjects With NYHA II–III Systolic Heart Failure

George F. Wohlford, Benjamín Van Tassell, Hayley Billingsley et al. · Journal of Cardiovascular Pharmacology · 2020 · 138 citations · Full text

Heart Failure, Cardiovascular Pharmacology, Pharmacotherapy +18

Inflammasome formation in the lungs of patients with fatal COVID-19

Stefano Toldo, Rossana Bussani, Vincenzo Nuzzi et al. · Inflammation Research · 2020 · 137 citations · Full text

Pulmonary Pathology, Inflammatory Lung Disease, Lung Inflammation +11

Adipocytokine Levels in Obese and Non-obese Subjects: an Observational Study

Giuseppe Derosa, Elena Fogari, Angela D’Angelo et al. · Inflammation · 2013 · 113 citations

Obesity, Nutrition, Metabolic Syndrome +10

Effects of berberine on lipid profile in subjects with low cardiovascular risk

Giuseppe Derosa, Angela D’Angelo, Aldo Bonaventura et al. · Expert Opinion on Biological Therapy · 2013 · 106 citations

NLRP3 Inflammasome in Acute Myocardial Infarction

Adolfo G Mauro, Aldo Bonaventura, Eleonora Mezzaroma et al. · Journal of Cardiovascular Pharmacology · 2019 · 98 citations